» Articles » PMID: 21791555

RNA Interference in Mammals: Behind the Screen

Overview
Date 2011 Jul 28
PMID 21791555
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery of RNA interference (RNAi) and the development of technologies exploiting its biology have enabled scientists to rapidly examine the consequences of depleting a particular gene product in a cell or an animal. The availability of genome-wide RNAi libraries targeting the mouse and human genomes has made it possible to carry out large scale, phenotype-based screens, which have yielded seminal information on diverse cellular processes ranging from virology to cancer biology. Today, several strategies are available to perform RNAi screens, each with their own technical and monetary considerations. Special care and budgeting must be taken into account during the design of these screens in order to obtain reliable results. In this review, we discuss a number of critical aspects to consider when planning an effective RNAi screening strategy, including selecting the right biological system, designing an appropriate selection scheme, optimizing technical aspects of the screen, and validating and verifying the hits. Similar to an artistic production, what happens behind the screen has a direct impact on its success.

Citing Articles

Genome-Wide High-Throughput RNAi Screening for Identification of Genes Involved in Protein Production.

Inwood S, Cheng K, Betenbaugh M, Shiloach J Methods Mol Biol. 2024; 2810:317-327.

PMID: 38926288 DOI: 10.1007/978-1-0716-3878-1_20.


Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk.

Ahmad M, Weiswald L, Poulain L, Denoyelle C, Meryet-Figuiere M J Exp Clin Cancer Res. 2023; 42(1):173.

PMID: 37464436 PMC: 10353155. DOI: 10.1186/s13046-023-02741-x.


Application of the CRISPR/Cas9 System to Study Regulation Pathways of the Cellular Immune Response to Influenza Virus.

Prokhorova D, Zhukova Eschenko N, Lemza A, Sergeeva M, Amirkhanov R, Stepanov G Viruses. 2022; 14(2).

PMID: 35216030 PMC: 8879999. DOI: 10.3390/v14020437.


Genome-wide screens identify specific drivers of mutant promoters.

Shanmugam R, Ozturk M, Low J, Akincilar S, Chua J, Thangavelu M Proc Natl Acad Sci U S A. 2022; 119(3).

PMID: 35027447 PMC: 8784157. DOI: 10.1073/pnas.2105171119.


RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer.

Haque S, Cook K, Sahay G, Sun C Pharmaceutics. 2021; 13(10).

PMID: 34683988 PMC: 8537780. DOI: 10.3390/pharmaceutics13101694.